iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/24713758/
Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;24(2):108-114.

Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study

Pantelis Oustamanolakis  1 , Ioannis E Koutroubakis  1 , Ippokratis Messaritakis  2 , Maria Niniraki  3 , Elias A Kouroumalis  1
Affiliations

Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study

Pantelis Oustamanolakis et al. Ann Gastroenterol. 2011.

Abstract

Background: No reliable biochemical markers exist for the differentiation between iron deficiency anemia (IDA) and anemia of chronic disease (ACD) in the setting of inflammatory bowel disease (IBD). The aim of this study was to investigate the use of soluble transferrin receptor (sTfR) and sTfR-ferritin (sTfR-F) index in the evaluation of anemia in patients with IBD.

Methods: One hundred IBD patients [49 ulcerative colitis (UC), 51 Crohn's disease (CD)] and 102 healthy controls were enrolled. Serum levels of ferritin, transferrin saturation and sTfR were analyzed in all patients and controls. sTfR-F index was calculated based on the ratio: sTfR/ log ferritin. The value of sTfR and sTfR-F for diagnosis of IDA was assessed.

Results: Forty two IBD patients (41% of UC and 42.9 % of CD) fulfilled the WHO criteria for the diagnosis of anemia. Among them thirty (30 %) had IDA, four (4%) had ACD and eight (8%) had mixed IDA/ACD. Patients with IDA had significantly higher sTfR and sTfR-F index levels compared with those without IDA (P<0.0001). Both sTfR and sTfR-F index were not correlated with CRP levels or disease activity. High sTfR levels (>1.8 mg/L) had sensitivity 81% and specificity 80%, whereas high sTfR-F index (>1.4) had sensitivity 91% and specificity 92% for the diagnosis of IDA.

Conclusion: These results suggest that the sTfR-F index seems to be very efficient in the detection and diagnosis of IDA, among patients with IBD.

Keywords: Crohn’s disease; anemia; ferritin; iron deficiency; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

Figures

Figure 1
Figure 1
Distribution of soluble transferrin receptor (sTfR) levels in patients with inflammatory bowel disease (IBD) and iron deficiency anemia (IDA, n=30) and IBD patients without IDA (Non IDA, n=70). Boxes indicate the interquartile range with median value. Bars show the 5th and 95th percentiles.
Figure 2
Figure 2
Distribution of soluble transferrin receptor –ferritin (sTfR-F) index in patients with inflammatory bowel disease (IBD) and iron deficiency anemia (IDA, n=30) and IBD patients without IDA (Non IDA, n=70). Boxes indicate the interquartile range with median value. Bars show the 5th and 95th percentiles.
Figure 3
Figure 3
Receiver operating characteristic (ROC) curves for soluble transferrin receptor (sTfR) and sTfR –ferritin (sTfRF) index, in the diagnosis of iron deficiency anemia in patients with inflammatory bowel disease
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gasche C, Lomer MCE, Cavill I, Weiss G. Iron, anemia, and inflammatory bowel diseases. Gut. 2004;53:1190–1197. - PMC - PubMed
    1. Bergamaschi G, Di Sabatino A, Albertini R, et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica. 2010;95:199–205. - PMC - PubMed
    1. Gomollón F, Gisbert JP. Anaemia and inflammatory bowel diseases. World J Gastroenterol. 2009;15:4659–4665. - PMC - PubMed
    1. Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica. 2010;95:175–178. - PMC - PubMed
    1. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:1545–1553. - PubMed

LinkOut - more resources